Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Down 47.3% in April

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a large drop in short interest in April. As of April 30th, there was short interest totaling 408 shares, a drop of 47.3% from the April 15th total of 774 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily volume of 2,035 shares, the days-to-cover ratio is currently 0.2 days.

Innovator IBD Breakout Opportunities ETF Stock Down 2.3%

NYSEARCA:BOUT traded down $1.09 on Friday, reaching $45.88. The stock had a trading volume of 915 shares, compared to its average volume of 5,036. The company has a market capitalization of $16.06 million, a P/E ratio of 28.69 and a beta of 1.05. Innovator IBD Breakout Opportunities ETF has a 1-year low of $34.57 and a 1-year high of $47.00. The stock has a fifty day moving average price of $41.89 and a 200-day moving average price of $39.48.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

A number of large investors have recently bought and sold shares of the business. Osaic Holdings Inc. raised its position in Innovator IBD Breakout Opportunities ETF by 39.7% in the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after purchasing an additional 597 shares during the last quarter. Comprehensive Wealth Management LLC increased its stake in shares of Innovator IBD Breakout Opportunities ETF by 60.5% in the third quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock valued at $411,000 after buying an additional 3,976 shares in the last quarter. Finally, Susquehanna International Group LLP increased its stake in shares of Innovator IBD Breakout Opportunities ETF by 42.6% in the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after buying an additional 7,817 shares in the last quarter.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.